Democratic Party leaders and their donors bear responsibility for the increasingly widespread view of trans rights as ...

In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...

Hulu has released some of the first images of the sixth and final season of The Handmaid’s Tale, which is slated to premiere ...

The first look photos - and a teaser from Disney - deliver the first tease at what the sixth and final season of the hit Hulu ...

The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $96.57 which represents a decrease of $-1.33 or -1.36% from the prior close of $97.9. The stock opened at $96.05 and ...

Open burning is banned statewide until Jan. 15, 2025, according to the Massachusetts Department of Environmental Protection.

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...

Disclosure: This study was supported in part by the Gilead Biomedical Research Fellowship Program.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...